CIK 0000926617 · Non-accelerated filer<br>Smaller reporting company
Aspira Women's Health Inc.
Sign in to watch- Ticker
- AWHL
- Exchange
- OTC
- Industry
- In Vitro & In Vivo Diagnostic Substances
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 330595156
- Phone
- 512-519-0400
- Business address
- 12117 BEE CAVES ROAD BUILDING THREE, SUITE 100, AUSTIN, TX, 78738
- Former names
- VERMILLION, INC., CIPHERGEN BIOSYSTEMS INC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2024-08-12 | Vos Ellen O'Connor Director | Grant or award | +16,593 | 52,739 | ||
| 2024-07-09 | SCHULER JACK W 10% owner | Purchase | +6,536 | 6,536 | ||
| 2024-07-09 | SCHULER JACK W 10% owner | Purchase · Warrant (Right to Buy) | +6,536 | 6,536 | ||
| 2024-07-09 | Parnell Winfred Director | Grant or award | +3,268 | 34,781 | ||
| 2024-07-09 | Parnell Winfred Director | Grant or award · Warrant (Right to buy) | +3,268 | 3,268 | ||
| 2024-07-09 | Herchuk Jannie Prestridge Director | Grant or award | +4,902 | 28,735 | ||
| 2024-07-09 | Herchuk Jannie Prestridge Director | Grant or award · Warrant (Right to buy) | +4,902 | 4,902 | ||
| 2024-07-09 | Vos Ellen O'Connor Director | Grant or award | +3,268 | 36,146 | ||
| 2024-07-09 | Vos Ellen O'Connor Director | Grant or award · Warrant (Right to buy) | +3,268 | 3,268 | ||
| 2024-07-09 | Sandford Nicole CEO | Grant or award | +13,072 | 83,668 | ||
| 2024-07-09 | Sandford Nicole CEO | Grant or award · Warrant (Right to buy) | +13,072 | 13,072 | ||
| 2024-07-09 | Cavanaugh Stefanie L. Director | Grant or award | +3,268 | 38,172 | ||
| 2024-07-09 | Cavanaugh Stefanie L. Director | Grant or award · Warrant (Right to buy) | +3,268 | 3,268 | ||
| 2024-05-31 | Sandford Nicole Chief Executive Officer | Purchase | +9,493 | $2.42 | $23K | 70,596 |
| 2024-05-13 | Hombeck Torsten Chief Financial Officer | Grant or award · EMPLOYEE STOCK OPTION (RIGHT TO BUY) | +22,000 | 22,000 | ||
| 2024-05-13 | Sandford Nicole Chief Executive Officer | Grant or award · EMPLOYEE STOCK OPTION (RIGHT TO BUY) | +80,000 | 80,000 | ||
| 2024-05-03 | Hombeck Torsten Chief Financial Officer | Grant or award · EMPLOYEE STOCK OPTION (RIGHT TO BUY) | +6,667 | $3.20 | $21K | 6,667 |
| 2024-05-03 | Milligan Sandra President | Grant or award · EMPLOYEE STOCK OPTION (RIGHT TO BUY) | +30,000 | 30,000 | ||
| 2024-02-15 | Sandford Nicole President & CEO | Grant or award · Employee stock option (right to buy) | +30,000 | 30,000 | ||
| 2024-02-14 | Hombeck Torsten Chief Financial Officer | Grant or award · Employee stock option (right to buy) | +20,000 | 20,000 |
Page 6 of 15 · 296 trades